AnalystsBill Maughan
Bill Maughan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4737 out of 5217 analysts
Average Return
-9.3%
Win Rate
37%7 out of 19
Risk vs Reward
Poor
Good

Bill Maughan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Merus NvMRUS
+129.26%$21.94$50.30
2023-11-02 -
2024-11-01
Strong Buy
Dianthus Therapeutics IncDNTH
+100.26%$38.88$77.86
2025-09-17 -
2026-03-13
Strong Buy
Krystal Biotech IncKRYS
+77.87%$139.01$247.26
2025-07-01 -
2026-03-13
Strong Buy
Wave Life Sciences LtdWVE
+60.94%$8.09$13.02
2025-10-15 -
2026-03-13
Strong Buy
Annexon IncANNX
+39.41%$4.06$5.66
2025-12-02 -
2026-03-13
Strong Buy

Bill Maughan Analyst Color

Get additional color on Bill Maughan's coverage of popular stocks

Bill Maughan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dianthus Therapeutics IncDNTH
2Strong Buy$130.00+66.97%Maintains
5 days ago
Ocular Therapeutix IncOCUL
1Strong Buy$28.00+219.63%Maintains
12 days ago
Korro Bio IncKRRO
2Strong Buy$18.00+40.63%Upgrades
24 days ago
Caribou Biosciences IncCRBU
1Strong Buy$13.00+591.49%Initiates Coverage On
a month ago
Cellectis SaCLLS
1Strong Buy$9.00+163.16%Initiates Coverage On
3 months ago
Wave Life Sciences LtdWVE
2Strong Buy$47.00+260.98%Maintains
3 months ago
Annexon IncANNX
1Strong Buy$17.00+200.35%Initiates Coverage On
3 months ago
Y Mabs Therapeutics IncYMAB
3Hold$8.60-0.12%Downgrades
7 months ago
Krystal Biotech IncKRYS
1Strong Buy$190.00-23.16%Initiates Coverage On
8 months ago
Crispr Therapeutics AgCRSP
1Hold$45.00-7.69%Downgrades
9 months ago
Nkarta IncNKTX
2Strong Buy$15.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
1Strong Buy$9.00N/AMaintains
2 years ago
Immunocore Holdings PLCIMCR
3Hold$67.00N/AMaintains
2 years ago
Moderna IncMRNA
3Hold$106.00N/AMaintains
2 years ago
Century Therapeutics IncIPSC
1Strong Buy$24.00N/AMaintains
2 years ago
Bicycle Therapeutics PLCBCYC
1Strong Buy$60.00N/AReiterates
2 years ago
Merus NvMRUS
1Strong Buy$45.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.